Form 8-K Pacira Pharmaceuticals, For: May 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Pacira Pharma (PCRX) Tops Q1 EPS by 8c; EXPAREL Sales Rose 14%
May 2, 2016 8:57 AM EDTPacira Pharma (NASDAQ: PCRX) reported Q1 EPS of $0.15, $0.08 better than the analyst estimate of $0.07. Revenue for the quarter came in at $65.5 million versus the consensus estimate of $67.11 million.
EXPAREL net product revenues were $63.8 million in the first quarter of 2016, compared to $56.0 million in... More



